Wallace L. Hall Jr - Apr 17, 2025 Form 4 Insider Report for Tvardi Therapeutics, Inc. (TVRD)

Role
Director
Signature
/s/ Dan Conn, Attorney-in-Fact
Stock symbol
TVRD
Transactions as of
Apr 17, 2025
Transactions value $
$0
Form type
4
Date filed
4/21/2025, 05:15 PM
Previous filing
Apr 17, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TVRD Stock Option (right to buy) Award $0 +12K $0.00 12K Apr 17, 2025 Common Stock 12K $17.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest and become exercisable over three years in 12 equal quarterly installments commencing on July 17, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.